Come up with a name for your new list and we'll add to it:
MValve Technologies raised a round of funding on July 06, 2014. Investors include
Boston Scientific Corporation.
MValve technologies is an Israeli-American company dedicated to providing a solution to the unmet clinical need of Mitral Regurgitation - an abnormal reversal of blood flow from the heart's left ventr…